The vaccine candidate was originally developed by the Israel Institute for Biological Research (IIBR), which operates under the auspices of the Prime Minister’s Office and works closely with the Defense Ministry.
The institute’s strategic and technical capabilities are shrouded in secrecy, but this week, The Jerusalem Post gained access to new data that show BriLife could be more effective against mutations and confer lasting immunity.
The Israeli vaccine could potentially address COVID better than other technologies, according to the CEO of NeuroRx.
Oramed Pharmaceuticals, the developer of the Oravax oral COVID-19 vaccine candidate, has announced a partnership with Mexico’s Genomma Lab Internacional to help fast-track a Phase II clinical trial and gain emergency use authorization in the Latin American country.
Only about 58% of Mexico’s population has been jabbed with one dose of a coronavirus vaccine, averaging around 4,500 new cases per day.
The Biden administration is expected to announce this week it is purchasing 10 million courses of treatment Pfizer’s covid pill, a multibillion dollar investment in a medication that officials hope will help change the trajectory of the pandemic by staving off many hospitalizations and deaths, according to two people with knowledge of the transaction.
-call me Nostradamus, but I called this.
Officials see Pfizer’s pill, and another by Merck, as potential gamechangers to tame the pandemic.
Freedom of Information Act requests are rarely speedy, but when a group of scientists asked the federal government to share the data it relied upon in licensing Pfizer’s COVID-19 vaccine, the response went beyond typical bureaucratic foot-dragging.
55 years and longer.
That’s how long the Food & Drug Administration in court papers this week proposes it should be given to review and release the trove of vaccine-related documents responsive to the request. If a federal judge in Texas agrees, plaintiffs Public Health and Medical Professionals for Transparency can expect to see the full record in 2076.
“Fountain is an example of a biotech company emerging as a direct result of basic research, in this case the biology of aging,” said Dr Rando, founder and chairman of Fountain. “The company’s screening and discovery platform is built upon foundational research showing that the age of a cell can be modulated by factors in the cell’s environment. By identifying compounds that work through these pathways, we seek to restore youthful resilience to cells and tissues, leading to therapies that treat or even prevent chronic diseases of aging.”
Longevity funding: Eli Lilly and R42 Group join the party as Khosla-backed biopharma brings total Series A to $26 million.
Every one of us has a magical tool in our pockets or purses. We should be able to enter an unknown building, navigate to our desired location, know where the elevators are, and gain access seamlessly.
But we can’t.
Our buildings cost millions or even billions of dollars. They have the latest technology. But they don’t know how many people are in them. They don’t know when to turn the lights off, or learn when to start warming or cooling office or meeting space. They don’t reposition elevators for maximum efficiency, and they can’t tell first responders where the fire is, where the medical emergency is, or what the quickest route up is. Nor can they tell occupants that the air is clean today, or that there’s an elevated level of volatile organic compounds because the floors were just waxed yesterday.
Fundamental Research On Ethical & Trustworthy Artificial Intelligence, For Health, Environment, And A Sustainable Future — Dr. Patrick van der Smagt, Ph.D., Director, ArtificiaI Intelligence Research, Volkswagen.
Dr. Patrick van der Smagt is Director of ArtificiaI Intelligence Research, Volkswagen AG, and Head of Argmax. AI (https://argmax.ai/), the Volkswagen Group Machine Learning Research Lab, in Munich, focusing on a range of research domains, including probabilistic deep learning for time series modelling, optimal control, reinforcement learning robotics, and quantum machine learning.
Dr. van der Smagt is also a research professor in the Computer Science faculty at Eötvös Loránd University in Budapest.
Dr. van der Smagt previously directed a lab as professor for machine learning and biomimetic robotics at the Technical University of Munich while leading the machine learning group at the research institute fortiss, and before that, founded and headed the Assistive Robotics and Bionics Lab at DLR, the German Aerospace Center.
Besides publishing numerous papers and patents on machine learning, robotics, and motor control, Dr. van der Smagt has won a number of awards, including the 2013 Helmholtz-Association Erwin Schrödinger Award, the 2014 King-Sun Fu Memorial Award, the 2013 Harvard Medical School/MGH Martin Research Prize, the 2018 Webit Best Implementation of AI Award, and best-paper awards at various machine learning and robotics conferences and journals.
A chemist in D.C.’s crime lab has discovered a new synthetic opioid being used on the streets of the District. The lab immediately alerted first responders about the possibility the drug could be resistant to the lifesaving antidote Narcan.
As part of her work testing used syringes to surveil the drug supply for new threats, chemist Alexandra Evans discovered the first known sample of Protonitazene in D.C.
Google is secretly working with the world’s leading neuroscientists on mapping the entire Human Brain. Neuroscientists at have released the most detailed 3D map of the mammalian brain ever made. Google has helped them by funding their goal to create the most detailed map yet of the connections within the human brain. It reveals a staggering amount of detail, including patterns of connections between neurons, as well as what may be a new kind of neuron.
The applications in the field of Brain Computer Interfaces or understanding medical conditions are staggering. But it’s doubtful that this will just help companies such as Neuralink develop advanced future brain computer interfaces and will likely lead to Google doing evil things by understanding people’s way of thinking and delivering ads to them. –
If you enjoyed this video, please consider rating this video and subscribing to our channel for more frequent uploads. Thank you! smile – TIMESTAMPS: 00:00 A Paradigm Shift in Brain Research. 00:53 What did actually happen? 02:54 How Scientists mapped the Human Brain. 05:05 What this does for neuroscientists. 06:23 How long until we understand the Brain? 08:08 Last Words. – #google #bci #neuralink
Nvidia (NVDA) CEO Jensen Huang doesn’t see the global chip shortage coming to an end anytime soon. The head of the largest chip maker by market cap, Huang is fresh off his virtual keynote at Nvidia’s GTC conference where he announced advances in the company’s metaverse and AI efforts.
But Nvidia still makes the bulk of its revenue, about 47% in Q2, from the sale of its gaming cards. And those continue to be in short supply due to the pandemic-induced chip crisis.
“I think that through the next year, demand is going to far exceed supply. We don’t have any magic bullets in navigating the supply chain,” Huang told Yahoo Finance Live on Wednesday.
